JT

Jeevansh Tyagi

Active Director Director DIN 11042673
DIN 11042673 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Jeevansh Tyagi

Data last updated:

Jeevansh Tyagi is a Director at Psj Biochem Diagnostic Private Limited (since 2025). The company operates in Healthcare. Psj Biochem Diagnostic Private Limited reported revenue of ₹3.36 Cr (FY 2025).

DIN 11042673
Primary Designation Director
Industry Healthcare
First Appointment 08 Apr 2025
Oldest Company Age 20 yrs
Largest company Psj Biochem Diagnostic Private Limited · ₹3.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Apr 20252006₹3.36 Cr (FY 2025)Active

Board colleagues of Jeevansh Tyagi

Directorship timeline

Open interactive timeline →
Psj Biochem Diagnostic Private Limited
Premium access

Shareholding and investment profile for Jeevansh Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeevansh Tyagi

Jeevansh Tyagi currently holds 1 directorship: Psj Biochem Diagnostic Private Limited (Director, since 08 Apr 2025, revenue ₹3.36 Cr (FY 2025)).

Jeevansh Tyagi was first appointed on 08 Apr 2025 as Director at Psj Biochem Diagnostic Private Limited.

The current boards of Jeevansh Tyagi's companies include Gunjan Tyagi (Psj Biochem Diagnostic Private Limited), Indu Tyagi (Psj Biochem Diagnostic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available